Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis

Molecular Biology Reports

Volumn 42, Issue 6, 2015, Pages 1029-1038

  Yao, Ying shui ^a   Li, Jie ^a   Jin, Yue long ^a   Chen, Yan ^a   He, Lian ping ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

Meta analysis; Obesity; Peroxisome proliferator activated receptor gamma (PPAR ); Polymorphism

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

BODY MASS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; META ANALYSIS; OBESITY; ODDS RATIO; RISK FACTOR;

BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; OBESITY; ODDS RATIO; POLYMORPHISM, GENETIC; PPAR GAMMA; RISK FACTORS;

EID: 84939960197     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3838-6     Document Type: Article

References (48)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 82:1–8
2. Sardinha LB, Santos DA, Silva AM et al (2012) Prevalence of overweight, obesity, and abdominal obesity in a representative sample of Portuguese adults. PLoS ONE 10:e47883
3. Li XY, Jiang Y, Hu N, Li YC, Zhang M, Huang ZJ, Zhao WH (2012) Prevalence and characteristic of overweight and obesity among adults in China, 2010. Zhonghua Yu Fang Yi Xue Za Zhi 46:683–686 (In Chinese)
4. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M (2011) Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378:815–825
5. Faith MS, Butryn M, Wadden TA, Fabricatore A, Nguyen AM, Heymsfield SB (2011) Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev 12:e438–e453
6. Haslam DW, James WP (2005) Obesity. Lancet 366:1197–1209
7. Wang R, Zhou D, Xi B et al (2011) ENPP1/PC-1 gene K121Q polymorphism is associated with obesity in European adult populations: evidence from a meta-analysis involving 24,324 subjects. Biomed Environ Sci 24:200–206
8. Rankinen T, Zuberi A, Chagnon YC et al (2006) The human obesity gene map: the 2005 update. Obesity (Silver Spring) 14:529–644
9. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813–819
10. Auwerx J (1999) PPARgamma, the ultimate thrifty gene. Diabetologia 42:1033–1049
11. Yen CJ, Beamer BA, Negri C et al (1997) Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241:270–274
12. Prakash J, Srivastava N, Awasthi S et al (2012) Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population. Am J Hum Biol 24:454–459
13. Bhatt SP, Misra A, Sharma M et al (2012) Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian Indians. Diabetes Technol Ther 14:828–834
14. Canizales-Quinteros S, Aguilar-Salinas CA, Ortiz-López MG et al (2007) Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico. Hum Biol 79:111–119
15. Ai ZH, Fang DC, Zhang ZH (2008) Association of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 with obesity in Chinese population. Acta Acad Med Mil Tertiae 30:691–693 (In Chinese)
16. Wang LP, Zhao LR, Cui HW, Yan MR, Yang L, Su XL (2012) Association between PPARγ2 Pro12Ala polymorphism and myocardial infarction and obesity in Han Chinese in Hohhot, China. Genet Mol Res 11:2929–2938
17. Ghoussaini M, Meyre D, Lobbens S et al (2005) Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 6:11
18. Srámková D, Kunesová M, Hainer V, Hill M, Vcelák J, Bendlová B (2002) Is a Pro12Ala polymorphism of the PPARgamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population? Ann N Y Acad Sci 967:265–273
19. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826
20. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
21. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
23. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
24. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
25. Ek J, Urhammer SA, Sørensen TI, Andersen T, Auwerx J, Pedersen O (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892–895
26. Clement K, Hercberg S, Passinge B et al (2000) The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord 24:391–393
27. Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Colantuoni V, Riccardi G (2000) Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study. Int J Obes Relat Metab Disord 24:1195–1199
28. Ochoa MC, Marti A, Azcona C et al (2004) Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents. Int J Obes Relat Metab Disord 28:S37–S41
29. Larsen TM, Larsen LH, Torekov SK et al (2005) Novel variants in the putative peroxisome proliferator-activated receptor gamma promoter and relationships with obesity in men. Obes Res 13:953–958
30. Zhang DF, Zhu JZ, Gao J, Guo WC, Yu XP, Wang FN (2005) The relationship among peroxisome proliferator-activated receptor γ2(PPARγ2) gene mutation and leptin secretion and adiposity in Shijiazhuang area. Chin J Birth Health Hered 13:25–26 (In Chinese)
31. Li XL, Lin Zhang, Yang WL, Wang N (2007) Correlation between Pro12Ala Polymorphism in PPARγ2 and Obesity. J Fujian Med Univ 41:423–425 (In Chinese)
32. Guo XJ, Wang HJ, MA J, Yin ZD, P YP (2008) Study on the relationship between peroxisome proliferator activated receptor-γ (PPARγ) gene polymorphism and obesity or abnormal glucose metabolism in adolescents. Chin J School Health 29:890–892 (In Chinese)
33. Ramírez-Salazar M, Pérez-Luque E, Fajardo-Araujo M, Garza SM, Malacara JM (2008) Effect of the Pro12Ala polymorphism of the PPAR gamma 2 gene on response to pioglitazone treatment in menopausal women. Menopause 15:1151–1156
34. Cauchi S, Nead KT, Choquet H et al (2008) The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 9:45
35. Mirzaei H, Akrami SM, Golmohammadi T et al (2009) Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects. Metab Syndr Relat Disord 7:453–458
36. Wang W, Zhang WW, Xie ZM, Li YR, Pei XF (2009) A pioneer study on relationship of peroxisome proliferator-activated receptor-γ2 and uncoupling protein 2 gene polymorphism with simple obesity in Chengdu. Mod Prev Med 36:938–941
37. Ben Ali S, Ben Yahia F, Sediri Y et al (2009) Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. Clin Biochem 42:1642–1647
38. Costa V, Casamassimi A, Esposito K et al (2009) Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy. J Biomed Biotechnol 2009:126917
39. Wang YX, Zhang D, Wu ZX, Ji HM, Song YP (2010) Association of PPARγ2 gene Pro12Ala polymorphism with overweight and obesity. Mod Prev Med 37:3945–3947 (In Chinese)
40. Wang YX, Suo LN, Wu ZX, Ji HM, Song YP (2010) Association of PPARγ2 gene Pro12Ala polymorphism with over weight and obesity of older persons. Chin J Gerontol 30:3244–3246 (In Chinese)
41. Bidzińska-Speichert B, Lenarcik A, Tworowska-Bardzińska U et al (2011) Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome. Ginekol Pol 82:426–429
42. Zuo HJ, Xie ZM, Zhang WW, Li YR, Wang W, Ding XB, Pei XF (2011) Gut bacteria alteration in obese people and its relationship with gene polymorphism. World J Gastroenterol 17:1076–1081
43. Tian ZG (2011) The relationship between polymorphism in PPAR-γ2 gene and type 2 diabetes Mellitus in Hui and Han People in Ningxia. Dissertation, Ningxia Medical University
44. Bell CG, Walley AJ, Froguel P (2005) The genetics of human obesity. Nat Rev Genet 6:221–234
45. Masud S, Ye S; SAS Group (2003) Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40:773–780
46. Paracchini V, Pedotti P, Taioli E (2005) Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 162:101–114
47. Beamer BA, Yen CJ, Andersen RE et al (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes 47:1806–1808
48. Stevens J, McClain JE, Truesdale KP (2008) Selection of measures in epidemiologic studies of the consequences of obesity. Int J Obes (Lond) Suppl 3:S60–66